美國Verinata Health www.verinata.com
Verinata Health位于加利福尼亞州的圣卡洛斯市，專攻非侵入性測試早期發(fā)現(xiàn)胎兒染色體異常。這是一項前瞻性、帶有一定探索性冒險性的的研究，臨床驗證他們第一個產(chǎn)前產(chǎn)前診斷測試。 
2013 年Illumina收購Verinata 

Verinata is driven by a sole, extraordinary purpose — maternal and fetal health. Our initial focus is to develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities using our proprietary technologies. We aim to reduce the anxiety associated with today’s multi-step process, the unacceptable false-positive rates, the non-specific and sometimes confusing results of current prenatal screening methods, as well as the risk of current invasive procedures. In support of national guidelines recommending first trimester aneuploidy risk assessment, we believe women who desire such an assessment should be offered a single blood draw test with a definitive result. Verinata has completed its blinded pivotal study to clinically validate the sensitivity and specificity of its first prenatal test. The verifi™ prenatal test is a non-invasive assay for the determination of the three primary chromosomal aneuploidies for trisomies 21, 18 and 13.